Enzo Biochem Inc/ US2941001024 /
| 2024-10-31 9:10:00 PM | Chg. 0.00 | Volume | Bid1:00:00 AM | Ask1:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.15USD | 0.00% | 66,871 Turnover: 73,168.62 |
1.05Bid Size: 500 | 1.50Ask Size: 1,700 | 60.08 mill.USD | - | - |
Assets
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 10.3000 | 9.1000 | 8.6000 | 7.7300 | 7.9480 | ||||||
| Intangible Assets | 20 | 11.8000 | 9.9000 | 8.1080 | 6.1550 | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | - | - | - | 23.6750 | 21.9080 | ||||||
| Inventories | 9.3000 | 8.8000 | 8.8000 | 8.6900 | 7.3960 | ||||||
| Accounts Receivable | 15.2000 | 14.1000 | 12.3000 | 12.4700 | 12.1090 | ||||||
| Cash and Cash Equivalents | 14.2000 | 15.1000 | 9 | 17.4550 | 18.1090 | ||||||
| Current Assets | 51.4000 | 40.4000 | 32.6000 | 40.7360 | 46.4860 | ||||||
| Total Assets | 109.5000 | 69.1000 | 59 | 64.4110 | 68.3940 | ||||||
Liabilities
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.9000 | 9 | 8.5000 | 8.2450 | 8.7620 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 11.1000 | 10.7000 | 12 | 13.1000 | 11.3400 | ||||||
| Liabilities | 20.7000 | 20 | 24.8000 | 27.4610 | 25.7880 | ||||||
| Share Capital | .4000 | .4000 | .4000 | .4430 | .4610 | ||||||
| Total Equity | 88.7000 | 49.1000 | 34.1000 | 36.9500 | 42.6060 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 109.5000 | 69.1000 | 59 | 64.4110 | 68.3940 | ||||||
Income Statement
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 102 | 103.1000 | 93.7000 | 95.9470 | 97.5990 | ||||||
| Depreciation (total) | - | - | - | 3.9710 | 3.7890 | ||||||
| Operating Result | -12.9000 | -40.5000 | -19 | -10.1800 | -1.2060 | ||||||
| Interest Income | .0100 | .0200 | -.0500 | -.2080 | -.2450 | ||||||
| Income Before Taxes | -12.8000 | -40.9000 | -18.9000 | -9.9050 | -2.2920 | ||||||
| Income Taxes | .1000 | -1.7000 | -.7000 | .0720 | -.0070 | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | -13 | -39.3000 | -18.2000 | -9.9770 | -2.2850 | ||||||
Per Share
Cash Flow
|
2011 US GAAP in mill. USD |
2012 US GAAP in mill. USD |
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -8.3000 | -6 | -10 | -1.6970 | -3.7000 | ||||||
| Cash Flow from Investing Activities | 13.5000 | 7.5000 | -1 | -.8330 | -1.7520 | ||||||
| Cash Flow from Financing | -.0700 | -.2000 | 4.8000 | 10.9170 | 6.2250 | ||||||
| Decrease / Increase in Cash | 5.4000 | .9000 | -6.1000 | 8.4480 | .6540 | ||||||
| Employees | 606 | 531 | 423 | 475 | 483 | ||||||
